KR910007528A - 벤조디아제핀 및 페닐피릴케톤 유도체의 용도 - Google Patents
벤조디아제핀 및 페닐피릴케톤 유도체의 용도 Download PDFInfo
- Publication number
- KR910007528A KR910007528A KR1019900017318A KR900017318A KR910007528A KR 910007528 A KR910007528 A KR 910007528A KR 1019900017318 A KR1019900017318 A KR 1019900017318A KR 900017318 A KR900017318 A KR 900017318A KR 910007528 A KR910007528 A KR 910007528A
- Authority
- KR
- South Korea
- Prior art keywords
- hiv
- diseases caused
- compound according
- effective amount
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 7-클로로-5-(2-피릴)-3H-1,4-벤조디아제핀-2(1H)-온 (화합물 A)의 안티-TAT활성을 나타낸다.
Claims (4)
- 레트로바이러스에 의해 야기되는 감염성 질환의 치료 또는 예방용, 특히 레트로바이러스 HIV(특히, HIV1)에 의해 야기되는 레트로바이러스성 질환의 세포변성적파괴 작용의 완화용 약제학적 제제를 제조하기 위한, 7-클로로-5-(2-피릴)-3H-1,4-벤조디아제핀-2(1H)-온, 2-글리신아미도-5-클로로페닐(2-피릴)케톤 및 이외 약제학적으로 허용되는 염을 함유하는 그룹의 화합물의 용도.
- 제1항에 따른 치료적 유효량의 화합물 및, 임의로 치료적 유효량의 제2의 안티-HIV화합물, 특정하게는 역전사효소 억제제(특히, ddC)를 함유하는, 제1항에 따른 질환의 치료 또는 예방을 위해 경구 또는 비경구투여에 적합한 용량 단위 형태의 항-바이러스 조성물.
- 제1항에 따른 용도에 대한 설명서와 함께, 약제학적 활성 성분으로서 제1항에 따른 화합물 및, 임의로 제2항에 따른 제2의 안티-HIV화합물을 함유하는 시판용 패키지.
- 주치의에 의해 개별적으로 결정된 일일용량, 특히 일일당 1회 이상 용량의 0.1 내지 10㎎/㎏체중의 항-바이러스 유효량, 바람직하게는 일일당 1회 또는 2회 용량의 1 내지 3㎎/㎏체중의 양(이때 형성된 치료적 형증 수준은 0.05 내지 10. 바람직하게는 0.1 내지 5μM이다)의 제1항에 따른 화합물을 투여하여, 레트로바이러스에 의해 야기되는 감염성 질환의 치료 또는 예방, 특히 레트로바이러스 HIV(특히, HIV 1)에 의해 야기되는 레트로바이러스성 질환의 세포변성적 파괴작용을 완화시키는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/428,555 US5070010A (en) | 1989-10-30 | 1989-10-30 | Method for determining anti-viral transactivating activity |
US07/428,558 US5041438A (en) | 1989-10-30 | 1989-10-30 | Method for treating retroviral infections with benzodiazepine compounds |
US428555 | 1989-10-30 | ||
US07/428,559 US5036101A (en) | 1989-10-30 | 1989-10-30 | Method for treating retroviral infections with aryl-(2-pyrryl) ketone compound |
US428558 | 1989-10-30 | ||
US428559 | 1989-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR910007528A true KR910007528A (ko) | 1991-05-30 |
Family
ID=27411588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900017318A KR910007528A (ko) | 1989-10-30 | 1990-10-29 | 벤조디아제핀 및 페닐피릴케톤 유도체의 용도 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0429868A3 (ko) |
JP (1) | JPH03151324A (ko) |
KR (1) | KR910007528A (ko) |
AU (1) | AU639273B2 (ko) |
CA (1) | CA2028758A1 (ko) |
HU (1) | HUT61195A (ko) |
IE (1) | IE903879A1 (ko) |
IL (1) | IL96133A0 (ko) |
PT (1) | PT95733A (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0475231A1 (en) * | 1990-09-10 | 1992-03-18 | F. Hoffmann-La Roche Ag | Benzodiazepines |
EP0491218A1 (en) * | 1990-12-17 | 1992-06-24 | F. Hoffmann-La Roche Ag | Benzodiazepinones |
TW221687B (ko) * | 1992-01-24 | 1994-03-11 | Hoffmann La Roche | |
WO1997032587A1 (en) * | 1996-03-04 | 1997-09-12 | Dana-Farber Cancer Institute | Methods for treating viral infections |
TW201111957A (en) * | 2009-09-28 | 2011-04-01 | Giga Byte Tech Co Ltd | Notebook computer docking station |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL131733C (ko) * | 1961-06-20 |
-
1990
- 1990-10-26 HU HU906906A patent/HUT61195A/hu unknown
- 1990-10-26 IE IE387990A patent/IE903879A1/en unknown
- 1990-10-26 IL IL96133A patent/IL96133A0/xx unknown
- 1990-10-29 JP JP2291659A patent/JPH03151324A/ja active Pending
- 1990-10-29 KR KR1019900017318A patent/KR910007528A/ko not_active Application Discontinuation
- 1990-10-29 CA CA002028758A patent/CA2028758A1/en not_active Abandoned
- 1990-10-29 AU AU65589/90A patent/AU639273B2/en not_active Ceased
- 1990-10-29 PT PT95733A patent/PT95733A/pt not_active Application Discontinuation
- 1990-10-29 EP EP19900120738 patent/EP0429868A3/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
HU906906D0 (en) | 1991-05-28 |
PT95733A (pt) | 1991-09-13 |
AU639273B2 (en) | 1993-07-22 |
AU6558990A (en) | 1991-05-02 |
IE903879A1 (en) | 1991-05-08 |
EP0429868A2 (de) | 1991-06-05 |
CA2028758A1 (en) | 1991-05-01 |
JPH03151324A (ja) | 1991-06-27 |
HUT61195A (en) | 1992-12-28 |
IL96133A0 (en) | 1991-07-18 |
EP0429868A3 (en) | 1992-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188782T3 (es) | Formulaciones farmaceuticas que contienen darifenacina. | |
KR930007441A (ko) | 의약품 | |
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
KR960700061A (ko) | 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence) | |
RU95121731A (ru) | Применение рилузола для лечения нейро-спида и способ получения лекарственного средства | |
JP2002528502A5 (ko) | ||
JP3018160B2 (ja) | 月経困難症及び/又は月経前症候群の軽減用薬剤 | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
ES2139842T3 (es) | Uso de la melatonina para tratar a pacientes que sufren drogodependencia. | |
CA2038744A1 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
KR970032872A (ko) | 아세틸살리실산을 함유하는 피부 손상 처치용 약물 | |
KR910007528A (ko) | 벤조디아제핀 및 페닐피릴케톤 유도체의 용도 | |
KR890004705A (ko) | 항바이러스성 제제 | |
CA2120001A1 (en) | Flavopereirine-based pharmaceutical composition and use thereof for treating hiv | |
KR900011461A (ko) | 트립스타틴을 유효성분으로 하는 치료제 | |
AR002727A1 (es) | El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion. | |
WO1994005300B1 (en) | Use of rapamycin in the treatment of aids | |
KR970005283A (ko) | 심근경색발생 후의 환자를 처치하기 위한 서트랄린의 용도 | |
BE1002256A3 (fr) | Medicaments. | |
RU93004785A (ru) | Твердые капсулы окфосфата цитарабина | |
WO2000043014A8 (en) | Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections | |
GB9713549D0 (en) | Pharmaceutical combination formulation | |
Hladovec et al. | Oral contraceptives, methionine and endothelial lesion | |
Batterman et al. | ANGINAL SYNDROME—Treatment with a Long-Acting Nitrate (Itramin Tosylate) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |